Evercore ISI raises Cohu stock price target on compute strength By Investing.com

Evercore ISI raised its price target on Cohu to $53 from $35 while keeping an Outperform rating, citing upside from near-term compute strength and a second-half 2026 recovery in auto-industrial markets. The firm now models 2026 revenue growth of 15% versus Street consensus at 12%, with the stock already up 98% year-to-date and valued at 61x next-twelve-month earnings. Additional support came from $30 million in follow-on Eclipse platform orders and a multi-unit AI datacenter processor order.

Analysis

The market is starting to price COHU less like a cyclical tester and more like a scarcity asset tied to AI/HBM packaging intensity. That matters because the incremental demand driver is not broad semiconductor unit growth but a shift in device mix toward higher-complexity test steps, which can support both utilization and pricing power even if overall wafer volumes are mediocre. The real second-order winner is the ecosystem around advanced compute: any supplier that raises test content per shipped AI/HPC device can grow faster than the underlying fab cycle.

What the consensus may be missing is that the valuation rerating can persist longer than fundamentals because COHU’s earnings power is still being revised off a low base. If management continues to convert “design-win” language into repeat orders, the stock can stay expensive for months despite seeming optically stretched; in these names, the multiple often leads the earnings inflection by 2-3 quarters. The downside is that any wobble in HBM/capex sentiment will hit the stock hard because expectations now assume a very clean 2026 ramp and margin expansion.

The key risk is timing: the stock can remain supported into the next print, but the setup becomes fragile once investors start demanding evidence that compute strength is durable beyond a single order cycle. If auto-industrial recovery slips or AI datacenter orders become lumpy, the market will quickly question the implied 2027-2028 earnings bridge. In that scenario, the stock can derate sharply even if the business is still growing, because the current price already discounts a high-quality, multi-year compounding story.

From a positioning standpoint, this is better expressed as a tactical momentum long than a long-duration fundamental core holding. The trade works while revisions are still moving up; once estimate upgrades stall, the asymmetry flips. The cleanest expression is to own the name into near-term catalysts but be prepared to monetize strength into any post-print pop or accelerated multiple expansion.

Key Decisions for Investors

• Long COHU into the next earnings catalyst or product/order update; target a 6-10 week window. Risk/reward favors upside while revisions are still being raised, but trim on any post-event gap-up if the stock moves more than 10-15% in a few sessions.
• Use a call spread in COHU rather than common stock for event exposure: buy 1-2 quarter out calls and finance with higher-strike calls. This keeps upside to a continued multiple expansion while capping the downside if AI/HBM order momentum slows.
• Pair trade: long COHU / short a slower-moving semiconductor capex proxy with less AI content sensitivity over the next 3-6 months. The goal is to isolate the upgrade cycle and reduce exposure to a broad semiconductor drawdown.
• If already long, set a hard review trigger if estimate revisions stop improving over the next 1-2 reporting cycles. A stalled revision trend would be the earliest signal that the market has fully discounted the 2026 story.
• For risk control, avoid adding aggressively after sharp one-day spikes; the stock is already in a momentum regime, so incremental entry should be on pullbacks of 5-8% rather than chasing strength.